Sotorasib is a synthetic compound used as an active pharmaceutical ingredient. It acts as an inhibitor of the RAS GTPase family and is investigated for its role in targeting the G12C mutation in the KRAS protein associated with certain cancers.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Sotorasib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Sotorasib
pharmaceutical raw material
15-oxoprostaglandin E1
pharmaceutical raw material
Riociguat metabolite M3
pharmaceutical raw material
Atazanavir sulfate
pharmaceutical raw material
Terbutaline
pharmaceutical raw material
The international HS code for Sotorasib (CAS 2296729-00-3) is 2933.59.
2933.59
2933 59 95
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-(4-methyl-2-propan-2-yl-3-pyridinyl)-4-[(2S)-2-methyl-4-prop-2-enoylpiperazin-1-yl]pyrido[2,3-d]pyrimidin-2-one
NXQKSXLFSAEQCZ-SFHVURJKSA-N
C[C@H]1CN(CCN1C2=NC(=O)N(C3=NC(=C(C=C32)F)C4=C(C=CC=C4F)O)C5=C(C=CN=C5C(C)C)C)C(=O)C=C
Sourcing Sotorasib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.